D-0251-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0251-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on February 5, 2021 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications The recall status is terminated (terminated November 3, 2021). Affected quantity: 20,475 vials.

Recall Details

Product Type
Drugs
Report Date
February 17, 2021
Initiation Date
February 5, 2021
Termination Date
November 3, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20,475 vials

Product Description

Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40

Reason for Recall

Failed Impurity/Degradation Specifications

Distribution Pattern

Nationwide

Code Information

JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021